Potential loss of prognostic significance of minimal residual disease assessment after R ‐CHOP‐based induction in elderly patients with mantle cell lymphoma in the era of rituximab maintenance

Hematological Oncology, EarlyView.

Source: Hematological Oncology - September 13, 2018 Category: Hematology Authors: PavelKlener , EvaFronkova , MarketaKalinova , DavidBelada , KristinaForsterova , RobertPytlik , PetraBlahovcova , MartinSimkovic , DavidSalek , HeidiMocikova , VitProchazka , AndreaJanikova , MartinaVaskova , EsterMejstrikova , Source Type: research